This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.

 
Web www.patentalert.com

< Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation

> N-aroyl piperazine derivatives as orexin receptor antagonists
~ 00451